Molsyns Research is a contract research and development organisation (CRDO), started in 2018 by experienced scientists with a customer-centric approach. Located in Ahmedabad, our experienced team specialises in the custom synthesis of complex organic compounds for use as reference standards by pharmaceutical industries around the world.
Molsyns Research maintains the highest standards of quality — certified to ISO 9001-2015, ISO 17025:2017 and GMP.
Molsyns believes in a customer-centric approach to build long-term relations and partnerships with clients. "Trust" and "Together we can…" are the success factors of Molsyns Research.
We believe social responsibility is about maintaining balance between our own growth and societal benefits. Molsyns has adopted a "Patient-centric" approach to serve science with quality within society.
Molsyns works with a quality mindset — "Quality in minds" creates a quality culture in the organisation. We build long-term client relationships by delivering products with quality and in a timely manner.
Director — Business Development
With over 16 years of experience in the pharmaceutical sector, Dr. Rajesh Desai stands as a distinguished leader in drug discovery, analytical research, and regulatory strategy. As the Director of Molsyns Research, he has transformed the organisation into a trusted CRDO known for its scientific precision, client-centric agility, and regulatory defensibility.
His ability to anticipate stakeholder needs, align technical rigor with business goals, and foster client trust has positioned Molsyns as a go-to CRDO for pharmaceutical companies worldwide.
Technical Director
With over 25 years of hands-on experience in pharmaceutical R&D, Deepak Bhagia is a seasoned innovator in drug discovery, medicinal chemistry, and strategic scientific partnerships. His career is distinguished by a deep technical command of complex chemical entities and a rare ability to translate cutting-edge research into scalable, real-world solutions.
His strategic oversight has enabled seamless execution of FTE collaborations with global pharmaceutical partners and accelerated development of reference standards, drug metabolites, and impurity profiling solutions.